Trastuzumab combined with irinotecan in patients with HER2-positive metastatic colorectal cancer: A phase II multicenter single-arm study and exploratory biomarker analysis.

v1

[{'name': 'Ting Xu', 'orcid': '0000-0002-1381-1609', 'country': 'CN', 'affiliation': 'Peking University'} and 44 more

[{'name': 'Ting Xu'

Type:article

Sign in to see the full record

Creating an account is free.

For data access, contact info@nobleid.org.